Mechanisms of Action of Anti‐GM1and Anti‐GQ1bGanglioside Antibodies in Guillain‐Barré Syndrome
Authors:
- Graham O'HanlonGOGraham O'Hanlon
- Gary PatersonGPGary Paterson
- Colin P. O'LearyCOColin P. O'Leary
- Jean VeitchJVJean Veitch
- George WilsonGWGeorge Wilson
- Mark RobertsMRMark Roberts
- Teresa TangTTTeresa Tang
- Angela VincentAVAngela Vincent
- 1 December 1997
- journal article
- review article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 176 (s2) , S144-S149
Abstract
Anti-GM1 and anti-GQ1b ganglioside antibodies are found in association with acute and chronic peripheral neuropathies, including Guillain-Barré syndrome. They are believed to arise as a result of molecular mimicry with immunogenic microbial polysaccharides. Although anti-ganglioside antibodies are suspected to play a causal role in neuropathy pathogenesis, the details of this have yet to be proven. The approach in this laboratory to solving this issue has been to generate anti-GM1 and anti-GQ1b monoclonal antibodies from peripheral blood lymphocytes of affected patients and to study their immunolocalization in peripheral nerve and their electrophysiologic effects in animal models in which peripheral nerve sites are exposed to anti-ganglioside antibodies. These data show that anti-ganglioside antibody-reactive epitopes are widely distributed in peripheral nerve and can cause electrophysiologic abnormalities in a variety of model systems; thus, these data support the view that anti-ganglioside antibody-reactive epitopes may directly contribute to neuropathy pathogenesis.Keywords
This publication has 3 references indexed in Scilit:
- Immunopathogenesis and treatment of the guillain‐barré syndrome—part IMuscle & Nerve, 1995
- Antiglycolipid antibodies in peripheral neuropathy: fact or fiction?Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Serum antibodies to gangliosides in guillain‐barré syndromeAnnals of Neurology, 1988